Literature DB >> 11857361

Cancer incidence in families with multiple glioma patients.

Niina Paunu1, Eero Pukkala, Pekka Laippala, Risto Sankila, Jorma Isola, Helena Miettinen, Kalle O J Simola, Pauli Helén, Heikki Helin, Hannu Haapasalo.   

Abstract

Twenty-four Finnish families with 2 or more glioma patients were identified through questionnaires sent to 369 consecutive glioma patients receiving surgery at Tampere University Hospital during 1983-94. To explore whether unusual cancer susceptibility is involved, the cancer risk of 2,664 family members was estimated using population-based data from the Finnish Cancer Registry. Among the total cohort of relatives, 88 cancers were observed during 1953-97. The overall cancer risk among 12 families with juvenile onset gliomas was significantly decreased (standardized incidence ratio [SIR] 0.6, 95% confidence interval [CI]: 0.4-0.9). Among 12 families with adult onset gliomas, the overall cancer risk was equal to that of the reference population (SIR 1.1, 95% CI: 0.8-1.4) whereas the risk of skin melanoma (SIR 4.0, 95% CI: 1.5-8.8) and meningioma (SIR 5.5, 95% CI: 1.1-16) were significantly increased. Several other tumors, including those associated with neurofibromatosis 1 and 2, tuberous sclerosis and Li-Fraumeni and Turcot syndromes were surveyed, but no elevated risks were observed. In conclusion, the presence of meningiomas and skin melanomas in glioma families may indicate a novel association as a cancer susceptibility trait. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11857361     DOI: 10.1002/ijc.10107

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.

Authors:  Siegal Sadetzki; Revital Bruchim; Bernice Oberman; Georgina N Armstrong; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Christoffer Johansen; Richard S Houlston; Sanjay Shete; Christopher I Amos; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Daniel Lachance; Nicholas A Vick; Ryan Merrell; Margaret Wrensch; Faith G Davis; Bridget J McCarthy; Rose Lai; Beatrice S Melin; Melissa L Bondy
Journal:  Eur J Cancer       Date:  2013-01-04       Impact factor: 9.162

2.  Sex-specific gene and pathway modeling of inherited glioma risk.

Authors:  Quinn T Ostrom; Warren Coleman; William Huang; Joshua B Rubin; Justin D Lathia; Michael E Berens; Gil Speyer; Peter Liao; Margaret R Wrensch; Jeanette E Eckel-Passow; Georgina Armstrong; Terri Rice; John K Wiencke; Lucie S McCoy; Helen M Hansen; Christopher I Amos; Jonine L Bernstein; Elizabeth B Claus; Richard S Houlston; Dora Il'yasova; Robert B Jenkins; Christoffer Johansen; Daniel H Lachance; Rose K Lai; Ryan T Merrell; Sara H Olson; Siegal Sadetzki; Joellen M Schildkraut; Sanjay Shete; Ulrika Andersson; Preetha Rajaraman; Stephen J Chanock; Martha S Linet; Zhaoming Wang; Meredith Yeager; Beatrice Melin; Melissa L Bondy; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

Review 3.  Familial aggregation of glioma: a pooled analysis.

Authors:  Michael E Scheurer; Carol J Etzel; Mei Liu; Jill Barnholtz-Sloan; Fredrik Wiklund; Björn Tavelin; Margaret R Wrensch; Beatrice S Melin; Melissa L Bondy
Journal:  Am J Epidemiol       Date:  2010-09-21       Impact factor: 4.897

Review 4.  Inherited predisposition to glioma.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Jasti S Rao; Chrissa Sioka
Journal:  Neuro Oncol       Date:  2009-11-23       Impact factor: 12.300

5.  Meningioma and schwannoma risk in adults in relation to family history of cancer.

Authors:  Deirdre A Hill; Martha S Linet; Peter M Black; Howard A Fine; Robert G Selker; William R Shapiro; Peter D Inskip
Journal:  Neuro Oncol       Date:  2004-10       Impact factor: 12.300

6.  Familial risks in nervous system tumours: joint Nordic study.

Authors:  K Hemminki; S Tretli; J H Olsen; L Tryggvadottir; E Pukkala; J Sundquist; C Granström
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

7.  Aggregation of cancer in first-degree relatives of patients with glioma.

Authors:  Michael E Scheurer; Carol J Etzel; Mei Liu; Randa El-Zein; Gladstone E Airewele; Beatrice Malmer; Kenneth D Aldape; Jeffrey S Weinberg; W K Alfred Yung; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

8.  Exploring the association between melanoma and glioma risks.

Authors:  Peter M Scarbrough; Igor Akushevich; Margaret Wrensch; Dora Il'yasova
Journal:  Ann Epidemiol       Date:  2014-03-04       Impact factor: 3.797

9.  Down-regulation of neogenin accelerated glioma progression through promoter Methylation and its overexpression in SHG-44 Induced Apoptosis.

Authors:  Xinmin Wu; Yunqian Li; Xilin Wan; Tabitha Mlowoka Kayira; Rangjuan Cao; Xingda Ju; Xiaojuan Zhu; Gang Zhao
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

10.  Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours.

Authors:  C Marian; A Scope; K Laud; E Friedman; F Pavlotsky; E Yakobson; B Bressac-de Paillerets; E Azizi
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.